SAVANNAH, Ga.--(BUSINESS WIRE)--Health Discovery Corporation (OTCBB: HDVY) announced today that it supports the American Cancer Society’s decision to issue new guidelines in the face of substantial data found in the largest prostate cancer studies ever conducted that were recently published in the New England Journal of Medicine in 2009. These published studies warned that using PSA to screen for prostate cancer doesn’t necessarily save lives, and noted any benefits can come at a high price including over-diagnosis of prostate cancer leading to unnecessary treatments which can result in impotence and incontinence which are potentially devastating and life changing side effects in these men.
